Liomont will produce COVID-19 vaccine from Astra Zeneca

The production facility of our customer Liomont in Ocoyoacac, Mexico, planned by IPB-Chemgineering Spain, will be used for the production of Astra Zeneca's COVID-19 vaccine as soon as approval is granted. Liomont will be responsible for the final production phase and will supply the entire Latin American market with the COVID-19 vaccine.

Chemgineering was responsible for the concept design of the entire production facility as well as the detail design of equipment and logistics for the facility planned for 2015. 

Read the details of the project in our references.

Read the complete press release of Liomont here:


Manuel Puerto

Managing Director IPB Chemgineering, Spain

This website uses cookies to provide you with the best possible experience. If you continue to browse our site, you consent to our use of cookies and to our privacy policy.